Federal Register #DEA-1755

Bulk Manufacturer Registration Application for Controlled Substances by Curia Missouri Inc.

This notice from the Drug Enforcement Administration (DEA) announces Curia Missouri Inc.'s application to register as a bulk manufacturer of controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - OEM/Vendor: - Curia Missouri Inc. - Products/Controlled Substances Requested for Bulk Manufacturing: - Gamma Hydroxybutyric Acid (drug code 2010, Schedule I) - Amphetamine (drug code 1100, Schedule II) - Lisdexamfetamine (drug code 1205, Schedule II) - Methylphenidate (drug code 1724, Schedule II) - Phenylacetone (drug code 8501, Schedule II) - Tapentadol (drug code 9780, Schedule II) - Notable Requirements: - Registration is for bulk manufacturing only - Substances may be used internally as intermediates or sold to customers - No other activities authorized for these drug codes under this registration - No specific purchase quantities provided (registration notice, not a procurement for delivery) - Docket No. DEA-1755 - No service line items or additional products listed

Description

Curia Missouri Inc. has applied to be registered as a bulk manufacturer of basic classes of controlled substances. The company plans to bulk manufacture the listed controlled substances for internal use intermediates or for sale to its customers. No other activities for these drug codes are authorized for this registration. Comments and objections to the application can be submitted electronically or in writing until October 26, 2026. The application is associated with Docket No. DEA-1755 and is published in the Federal Register, Volume 91, on August 25, 2026.

View original listing